Similar articles

• Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.

  Matsumura K, Campbell KP. Matsumura K, et al. Muscle Nerve. 1994 Jan;17(1):2-15. doi: 10.1002/mus.880170103. Muscle Nerve. 1994. PMID: 8264699 Review.
• Sarcoglycans in muscular dystrophy.

  Hack AA, Groh ME, McNally EM. Hack AA, et al. Microsc Res Tech. 2000 Feb 1-15;48(3-4):167-80. doi: 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T. Microsc Res Tech. 2000. PMID: 10679964 Review.
• Deficiency of adhalin in a patient with muscular dystrophy and cardiomyopathy.

  McNally EM, Bönnemann CG, Kunkel LM, Bhattacharya SK. McNally EM, et al. N Engl J Med. 1996 Jun 13;334(24):1610-1. doi: 10.1056/NEJM199606133342417. N Engl J Med. 1996. PMID: 8628353 No abstract available.
• A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.

  Iwata Y, Katanosaka Y, Arai Y, Komamura K, Miyatake K, Shigekawa M. Iwata Y, et al. J Cell Biol. 2003 Jun 9;161(5):957-67. doi: 10.1083/jcb.200301101. J Cell Biol. 2003. PMID: 12796481 Free PMC article.
• Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?

  Matsumura K, Saito F, Yamada H, Hase A, Sunada Y, Shimizu T. Matsumura K, et al. Cell Mol Biol (Noisy-le-grand). 1999 Sep;45(6):751-62. Cell Mol Biol (Noisy-le-grand). 1999. PMID: 10541473 Review.